358 related articles for article (PubMed ID: 25824995)
21. Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.
Lundman E; Gaup HJ; Bakkeheim E; Olafsdottir EJ; Rootwelt T; Storrøsten OT; Pettersen RD
J Cyst Fibros; 2016 May; 15(3):318-24. PubMed ID: 26795017
[TBL] [Abstract][Full Text] [Related]
22. Sweat chloride and immunoreactive trypsinogen in infants carrying two
Castellani C; Tridello G; Tamanini A; Assael BM
Arch Dis Child; 2017 Jul; 102(7):644-646. PubMed ID: 26755536
[TBL] [Abstract][Full Text] [Related]
23. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of Cystic Fibrosis in Screened Populations.
Farrell PM; White TB; Howenstine MS; Munck A; Parad RB; Rosenfeld M; Sommerburg O; Accurso FJ; Davies JC; Rock MJ; Sanders DB; Wilschanski M; Sermet-Gaudelus I; Blau H; Gartner S; McColley SA
J Pediatr; 2017 Feb; 181S():S33-S44.e2. PubMed ID: 28129810
[TBL] [Abstract][Full Text] [Related]
25. Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
Salinas DB; Ginsburg DK; Wee CP; Saeed MM; Brewington JJ
Pediatr Pulmonol; 2023 Apr; 58(4):1074-1084. PubMed ID: 36582049
[TBL] [Abstract][Full Text] [Related]
26. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
[TBL] [Abstract][Full Text] [Related]
27. Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length.
Salinas DB; Azen C; Young S; Keens TG; Kharrazi M; Parad RB
Genet Test Mol Biomarkers; 2016 Sep; 20(9):496-503. PubMed ID: 27447098
[TBL] [Abstract][Full Text] [Related]
28. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
29. CF versus CRMS: diagnostic challenges in cystic fibrosis.
Temme R; Roggenbuck J; McNamara J
Minn Med; 2012 Oct; 95(10):42-4. PubMed ID: 23193705
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation.
Farrell PM; White TB; Ren CL; Hempstead SE; Accurso F; Derichs N; Howenstine M; McColley SA; Rock M; Rosenfeld M; Sermet-Gaudelus I; Southern KW; Marshall BC; Sosnay PR
J Pediatr; 2017 Feb; 181S():S4-S15.e1. PubMed ID: 28129811
[TBL] [Abstract][Full Text] [Related]
31. A false positive newborn screening result due to a complex allele carrying two frequent CF-causing variants.
Bergougnoux A; Boureau-Wirth A; Rouzier C; Altieri JP; Verneau F; Larrieu L; Koenig M; Claustres M; Raynal C
J Cyst Fibros; 2016 May; 15(3):309-12. PubMed ID: 27117206
[TBL] [Abstract][Full Text] [Related]
32. Retrospective analysis of stored dried blood spots from children with cystic fibrosis and matched controls to assess the performance of a proposed newborn screening protocol in Switzerland.
Barben J; Gallati S; Fingerhut R; Schoeni MH; Baumgartner MR; Torresani T;
J Cyst Fibros; 2012 Jul; 11(4):332-6. PubMed ID: 22300503
[TBL] [Abstract][Full Text] [Related]
33. [Neonatal screening for cystic fibrosis].
Tellería Orriols JJ; Alonso Ramos MJ; Garrote Adrados JA; Fernández Carvajal I; Blanco Quirós A
An Esp Pediatr; 2002 Jul; 57(1):60-5. PubMed ID: 12139895
[TBL] [Abstract][Full Text] [Related]
34. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
[TBL] [Abstract][Full Text] [Related]
35. Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.
Fevola C; Dolce D; Tosco A; Padoan R; Daccò V; Claut L; Schgor T; Sepe A; Timpano S; Fabrizzi B; Piccinini P; Taccetti G; Bonomi P; Terlizzi V
Eur J Pediatr; 2024 Feb; 183(2):929-938. PubMed ID: 38054992
[TBL] [Abstract][Full Text] [Related]
36. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.
Sermet-Gaudelus I; Girodon E; Sands D; Stremmler N; Vavrova V; Deneuville E; Reix P; Bui S; Huet F; Lebourgeois M; Munck A; Iron A; Skalicka V; Bienvenu T; Roussel D; Lenoir G; Bellon G; Sarles J; Macek M; Roussey M; Fajac I; Edelman A
Am J Respir Crit Care Med; 2010 Oct; 182(7):929-36. PubMed ID: 20538955
[TBL] [Abstract][Full Text] [Related]
37. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.
Keiles S; Koepke R; Parad R; Kharrazi M;
J Cyst Fibros; 2012 May; 11(3):257-60. PubMed ID: 22209734
[TBL] [Abstract][Full Text] [Related]
38. Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians.
Terlizzi V; Farrell PM
Curr Probl Pediatr Adolesc Health Care; 2024 Jun; 54(6):101637. PubMed ID: 38811287
[TBL] [Abstract][Full Text] [Related]
39. Cystic fibrosis newborn screening: outcome of infants with normal sweat tests.
Edmondson C; Grime C; Prasad A; Cowlard J; Nwokoro CEC; Ruiz G; Wallis C; Balfour-Lynn IM
Arch Dis Child; 2018 Aug; 103(8):753-756. PubMed ID: 29113966
[TBL] [Abstract][Full Text] [Related]
40. Neonatal screening for cystic fibrosis: long-term clinical balance.
Mastella G; Zanolla L; Castellani C; Altieri S; Furnari M; Giglio L; Lombardo M; Miano A; Sciuto C; Pardo F; Magazzù G
Pancreatology; 2001; 1(5):531-7. PubMed ID: 12120233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
